219,736 Shares in Colgate-Palmolive Company $CL Purchased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. acquired a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, HoldingsChannel reports. The firm acquired 219,736 shares of the company’s stock, valued at approximately $17,367,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. HighPoint Advisor Group LLC increased its position in Colgate-Palmolive by 0.7% during the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after purchasing an additional 109 shares during the last quarter. Sunpointe LLC increased its position in Colgate-Palmolive by 4.0% during the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after purchasing an additional 117 shares during the last quarter. Capital Advisors Inc. OK increased its position in Colgate-Palmolive by 1.4% during the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after purchasing an additional 129 shares during the last quarter. Stratos Wealth Advisors LLC increased its position in Colgate-Palmolive by 4.5% during the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after purchasing an additional 130 shares during the last quarter. Finally, CYBER HORNET ETFs LLC increased its position in Colgate-Palmolive by 5.9% during the fourth quarter. CYBER HORNET ETFs LLC now owns 2,357 shares of the company’s stock worth $186,000 after purchasing an additional 131 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of CL opened at $90.26 on Monday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The stock has a market cap of $72.22 billion, a PE ratio of 35.12, a P/E/G ratio of 4.68 and a beta of 0.33. The firm has a 50-day simple moving average of $86.29 and a two-hundred day simple moving average of $85.69. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period last year, the business earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. As a group, analysts forecast that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date was Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CL shares. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Barclays lifted their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 5th. Finally, Jefferies Financial Group lifted their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Twelve equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.